Call for Abstracts
Abstract Submission Period
Abstract Submission Guidelines
Submit the completed Abstract Submission Form to abs-jbcs2027@c-linkage.co.jp in accordance with the regulations outlined below. The form can be downloaded from the bottom of this page.
Abstract Format and Limits
| Abstract Title | Limited to 100 characters (including spaces) |
|---|---|
| Abstract Body |
|
| Figure/Table | Limited to 1 figure or table Only JPEG or GIF formats are accepted. |
| Authors | Limited to 20 authors |
| Affiliations | Limited to 20 affiliations |
Please do not submit duplicate abstracts.
Late submissions will not be accepted.
Presentation Type
Abstracts can be accepted as Oral / Poster presentation.
The presentation format will be determined based on the results of peer review.
Oral Presentation
Abstracts with Innovative Approach will be selected as the Excellent Oral Presentations.
Poster Presentation
- Digital Poster Presentation (with On-site Presentation)
The presentation will be held on-site using a digital poster. - e-Poster (without On-site Presentation)
There will be no presentations or Q&As.
Attendees can view the e-Poster.
There will be no poster viewing at the venue.
Categories
Release of Presentation Data
Presentation data will be available on our website for approximately 3 months after the Meeting.
Please indicate your consent in the submission form.
On-demand Streaming
Although the provision of on-demand streaming has not yet been decided, please indicate whether you would consent to your presentation being used for this purpose if implemented.
Conflict of Interest Disclosure
The author is required to report applicable COI (Conflict of Interest) in the past three years by completing the “Conflict of Interest Disclosure” part in the Abstract Submission process. Please check the details here.
Ethical Review
Research that requires ethical review must, in principle, have received approval from the relevant ethics committee (e.g., your institution’s ethics committee or institutional review board) at the time of abstract submission.
If your application is currently under review, approval must be obtained by the time of the presentation.
Please note that any abstract lacking ethical approval at the time of the presentation will be withdrawn.
Notification of Acceptance
Notifications will be sent by e-mail in April 2027.
Hybrid Meeting
JBCS2027 will be held as a Hybrid Meeting (Onsite & Online).
Further details will be announced in due course.
Travel Grant
JBCS2027 Organizing Committee encourages breast care specialists from outside Japan to submit abstracts for General and Encore presentations.
After reviewing the guidelines below, please submit your abstract.
All applicants submitting abstracts are eligible to apply for the Travel Grant.
Guidelines
- The applicant must be the first author and the presenting author.
- Travel grants will be provided to awardees after their presentations onsite.
- Complimentary accommodation will not be provided. Travel and lodging arrangements are the responsibility of the applicant.
- Result of the review will be announced in the acceptance notifications e-mail in April, 2027.
- There are no age restrictions.
Please fill out the Abstract Submission Form and send it via email to abs-jbcs2027@c-linkage.co.jp.
Contact （Congress Secretariat）
- Abstract Submission Office, 35th Annual Meeting of the Japanese Breast Cancer Society
- c/o Convention Linkage, Inc.
- E-mail: abs-jbcs2027@c-linkage.co.jp